Nwam LLC acquired a new position in The Procter & Gamble Company (NYSE:PG - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 29,581 shares of the company's stock, valued at approximately $5,123,000.
A number of other large investors have also recently made changes to their positions in PG. Meridian Wealth Management LLC purchased a new stake in Procter & Gamble during the 3rd quarter valued at $10,072,000. Icon Wealth Advisors LLC increased its position in Procter & Gamble by 4,621.9% during the third quarter. Icon Wealth Advisors LLC now owns 1,285,923 shares of the company's stock valued at $222,722,000 after acquiring an additional 1,258,690 shares during the last quarter. Studio Investment Management LLC raised its stake in shares of Procter & Gamble by 0.3% in the third quarter. Studio Investment Management LLC now owns 42,122 shares of the company's stock valued at $7,296,000 after acquiring an additional 137 shares during the period. GM Advisory Group LLC boosted its stake in shares of Procter & Gamble by 2.2% during the 3rd quarter. GM Advisory Group LLC now owns 13,959 shares of the company's stock worth $2,418,000 after purchasing an additional 301 shares during the period. Finally, Allen Capital Group LLC grew its holdings in Procter & Gamble by 5.1% during the 3rd quarter. Allen Capital Group LLC now owns 8,479 shares of the company's stock valued at $1,469,000 after purchasing an additional 414 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Price Performance
Shares of PG stock opened at $174.48 on Friday. The stock's 50-day moving average is $170.00 and its 200 day moving average is $168.54. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The company has a market cap of $410.91 billion, a P/E ratio of 29.87, a PEG ratio of 3.69 and a beta of 0.42.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the previous year, the firm earned $1.83 EPS. The company's quarterly revenue was down .6% compared to the same quarter last year. Research analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.31%. Procter & Gamble's dividend payout ratio is presently 69.48%.
Wall Street Analyst Weigh In
Several analysts have issued reports on PG shares. Evercore ISI raised their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research note on Monday, October 21st. Morgan Stanley boosted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a report on Monday, October 21st. Dbs Bank lowered Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 1st. StockNews.com lowered shares of Procter & Gamble from a "buy" rating to a "hold" rating in a research note on Thursday, August 1st. Finally, Hsbc Global Res raised shares of Procter & Gamble to a "strong-buy" rating in a research note on Friday, October 4th. Nine equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Procter & Gamble presently has a consensus rating of "Moderate Buy" and an average price target of $178.00.
View Our Latest Stock Report on Procter & Gamble
Insider Buying and Selling
In other Procter & Gamble news, CEO Jon R. Moeller sold 37,240 shares of the business's stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the sale, the chief executive officer now owns 263,537 shares of the company's stock, valued at approximately $44,508,763.93. The trade was a 12.38 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO R. Alexandra Keith sold 1,992 shares of the firm's stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the transaction, the chief executive officer now directly owns 13,783 shares of the company's stock, valued at approximately $2,343,110. This represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 160,693 shares of company stock worth $27,311,345 in the last ninety days. 0.18% of the stock is owned by insiders.
About Procter & Gamble
(
Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.